Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability.

Tacrolimus (FK506) was used to prevent corneal allograft rejection in patients who were resistant to steroids and cyclosporine. However, the formulation for FK506 ocular delivery remained a challenge due to the drug's high hydrophobicity, high molecular weight, and eye's physiological and anatomical constraints. The aim of this project is to develop an ocular delivery system for FK506 based on a combined strategy of niosomes and mucoadhesive hyaluronic acid (HA), i.e., FK506HA-coated niosomes, which exploits virtues of both niosomes and HA to synergistically improve ophthalmic bioavailability. The FK506HA-coated niosomes were characterized with particle size, zeta potential, and rheology behavior. Mucoadhesion of FK506HA-coated niosomes to mucin was investigated through surface plasmon resonance in comparison with non-coated niosomes and HA solution. The results showed that niosomes possessed adhesion to mucin, and HA coating enhanced the adhesion. The in vivo precorneal retention was evaluated in rabbit, and the results showed that HA-coated niosomes prolonged the residence of FK506 significantly in comparison with non-coated niosomes or suspension. Aqueous humor pharmacokinetics test showed that area under curve of HA-coated niosomes was 2.3-fold and 1.2-fold as that of suspension and non-coated niosomes, respectively. Moreover, the synergetic corneal permeability enhancement of the hybrid delivery system on FK506 was visualized and confirmed by confocal laser scanning microscope. Overall, the results indicated that the hybrid system facilitated FK506 ocular delivery on mucoadhesion, precorneal retention, aqueous humor pharmacokinetics and transcorneal permeability. Therefore, HA-coated niosomes may be a promising approach for ocular targeting delivery of FK506.

[1]  Shi-you Zhou,et al.  Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty. , 2008, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[2]  T. Reinhard,et al.  Topical FK506 as immunoprophylaxis after allogeneic penetrating normal‐risk keratoplasty: a randomized clinical pilot study , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  K. Pathak,et al.  Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis. , 2015, Colloids and surfaces. B, Biointerfaces.

[4]  Jie Shen,et al.  Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[5]  P. Russo,et al.  Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery , 2002 .

[6]  Chuanbin Wu,et al.  Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  Shi-you Zhou,et al.  Determination of tacrolimus in rabbit aqueous humor by liquid chromatography-electrospray ionization tandem mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  J. Prydal,et al.  Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy , 1990, Eye.

[9]  Raida Al-Kassas,et al.  Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. , 2012, International journal of pharmaceutics.

[10]  G. Abdelbary.  Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes , 2011, Pharmaceutical development and technology.

[11]  I. Bravo-Osuna,et al.  Interfacial Interaction between Transmembrane Ocular Mucins and Adhesive Polymers and Dendrimers Analyzed by Surface Plasmon Resonance , 2012, Pharmaceutical Research.

[12]  E. Ferrary,et al.  Effect of liposomes on rheological and syringeability properties of hyaluronic acid hydrogels intended for local injection of drugs. , 2015, International journal of pharmaceutics.

[13]  Arto Urtti,et al.  Challenges and obstacles of ocular pharmacokinetics and drug delivery. , 2006, Advanced drug delivery reviews.

[14]  S. H. Leung,et al.  The contribution of anionic polymer structural features to mucoadhesion , 1987 .

[15]  F. Drago,et al.  Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits. , 2013, International journal of pharmaceutics.

[16]  R. Herrero-Vanrell,et al.  Hybrid Formulations of Liposomes and Bioadhesive Polymers Improve the Hypotensive Effect of the Melatonin Analogue 5-MCA-NAT in Rabbit Eyes , 2014, PloS one.

[17]  Kwangmeyung Kim,et al.  Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Amélie Bochot,et al.  Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea. , 2008, Experimental eye research.

[19]  J. Engbersen,et al.  Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[20]  R. Prescott,et al.  Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome , 1999, The British journal of ophthalmology.

[21]  S. Vyas,et al.  Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation , 2010, Journal of drug targeting.

[22]  H. Takeuchi,et al.  Evaluation of mucoadhesiveness of polymers by BIACORE method and mucin-particle method. , 2008, International journal of pharmaceutics.

[23]  Haeshin Lee,et al.  Chitosan-catechol: a polymer with long-lasting mucoadhesive properties. , 2015, Biomaterials.

[24]  M. Goldmann,et al.  Interactions of lipid monolayers with the natural biopolymer hyaluronic acid. , 2004, Biochimica et biophysica acta.

[25]  O. Camber,et al.  Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine. , 1989, Current eye research.

[26]  J. Hadgraft,et al.  Evaluation of Mucoadhesive Polymers in Ocular Drug Delivery. II. Polymer-Coated Vesicles , 1992, Pharmaceutical Research.

[27]  Asgar Ali,et al.  Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[28]  A. Díaz-Tahoces,et al.  The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain. , 2016, Biomaterials.

[29]  Yoshihiko Araki,et al.  Liposomes and nanotechnology in drug development: focus on ocular targets , 2012, International journal of nanomedicine.

[30]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[31]  L. Ambrosio,et al.  A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  Saeid Moghassemi,et al.  Nano-niosomes as nanoscale drug delivery systems: an illustrated review. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[33]  G. Hughes.  Nanostructure-mediated drug delivery. , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[34]  M. Alonso,et al.  Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers , 1997 .

[35]  Hirofumi Takeuchi,et al.  Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. , 2005, Advanced drug delivery reviews.

[36]  K. Girish,et al.  The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. , 2007, Life sciences.

[37]  M. Oechsner,et al.  Polyacrylic acid/polyvinylpyrrolidone bipolymeric systems. I. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndrome. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[38]  A. Ludwig,et al.  The use of mucoadhesive polymers in ocular drug delivery. , 2005, Advanced drug delivery reviews.

[39]  G. Sandri,et al.  Comparative study of nanosized cross-linked sodium-, linear sodium- and zinc-hyaluronate as potential ocular mucoadhesive drug delivery systems. , 2015, International journal of pharmaceutics.

[40]  Zhouhua Wang,et al.  Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[41]  O. Nuchuchua,et al.  Water-soluble β-cyclodextrin grafted with chitosan and its inclusion complex as a mucoadhesive eugenol carrier. , 2012, Carbohydrate polymers.

[42]  R. Gurny,et al.  Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[43]  T. Nishida,et al.  Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid , 2007, British Journal of Ophthalmology.

[44]  M. Naud,et al.  New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[45]  D. Meisner,et al.  Liposome ocular delivery systems , 1995 .

[46]  A. Díaz-Tahoces,et al.  A novel cationic niosome formulation for gene delivery to the retina. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[47]  Y. Zambito,et al.  Thiolated quaternary ammonium-chitosan conjugates for enhanced precorneal retention, transcorneal permeation and intraocular absorption of dexamethasone. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[48]  P. Ghosh,et al.  Interactions of hyaluronan (hyaluronic acid) with phospholipids as determined by gel permeation chromatography, multi-angle laser-light-scattering photometry and 1H-NMR spectroscopy. , 1994, International journal of biological macromolecules.

[49]  Weisan Pan,et al.  Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. , 2009, International journal of pharmaceutics.

[50]  Jong-Duk Kim,et al.  Mucoadhesive interaction of cysteine grafted poly(2-hydroxyethyl aspartamide) with pig mucin layer of surface plasmon resonance biosensor , 2009 .

[51]  R. Gurny,et al.  Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. , 2011, International journal of pharmaceutics.

[52]  D. Aggarwal,et al.  Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. , 2005, International journal of pharmaceutics.

[53]  Tomi Järvinen,et al.  Ocular absorption following topical delivery , 1995 .

[54]  R. Alany,et al.  Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. , 2011, Journal of pharmaceutical sciences.

[55]  N. Cho,et al.  Adsorption of hyaluronic acid on solid supports: role of pH and surface chemistry in thin film self-assembly. , 2015, Journal of colloid and interface science.

[56]  J. Rinehart,et al.  Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye , 2004, Current eye research.

[57]  Rakesh Kumar,et al.  Preparation and optimization of voriconazole microemulsion for ocular delivery. , 2014, Colloids and surfaces. B, Biointerfaces.

[58]  Shi-you Zhou,et al.  Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration. , 2009, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[59]  T. Vandamme.  Microemulsions as ocular drug delivery systems: recent developments and future challenges , 2002, Progress in Retinal and Eye Research.

[60]  D. Monti,et al.  Evaluation of high- and low-molecular-weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine , 1991 .

[61]  A. R. Gascón,et al.  A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases. , 2014, International journal of pharmaceutics.

[62]  Rakesh Kumar,et al.  Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[63]  Arto Urtti,et al.  Undefined role of mucus as a barrier in ocular drug delivery. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[64]  D J Berry,et al.  Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[65]  N. Yuksel,et al.  Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. , 2010, Journal of pharmaceutical sciences.

[66]  J. G. Souza,et al.  Topical delivery of ocular therapeutics: carrier systems and physical methods , 2014, The Journal of pharmacy and pharmacology.